Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer.
Beck M, Böhmer D, Aebersold DM, Albrecht C, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Sedlmayer F, Zips D, Zschaeck S, Budach V, Wiegel T, Ghadjar P; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO). Beck M, et al. Among authors: ganswindt u. Strahlenther Onkol. 2020 Feb;196(2):109-116. doi: 10.1007/s00066-019-01553-3. Epub 2019 Nov 29. Strahlenther Onkol. 2020. PMID: 31784804 Free article. Review.
70 Gy or more: which dose for which prostate cancer?
Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.
Risk of second malignancies after prostate irradiation?
Müller AC, Ganswindt U, Bamberg M, Belka C. Müller AC, et al. Among authors: ganswindt u. Strahlenther Onkol. 2007 Nov;183(11):605-9. doi: 10.1007/s00066-007-1786-y. Strahlenther Onkol. 2007. PMID: 17960335 Review.
Importance of Bak for celecoxib-induced apoptosis.
Müller AC, Handrick R, Elsaesser SJ, Rudner J, Henke G, Ganswindt U, Belka C, Jendrossek V. Müller AC, et al. Among authors: ganswindt u. Biochem Pharmacol. 2008 Oct 30;76(9):1082-96. doi: 10.1016/j.bcp.2008.08.012. Epub 2008 Aug 19. Biochem Pharmacol. 2008. PMID: 18778687
Toxicity and outcome of pelvic IMRT for node-positive prostate cancer.
Müller AC, Lütjens J, Alber M, Eckert F, Bamberg M, Schilling D, Belka C, Ganswindt U. Müller AC, et al. Among authors: ganswindt u. Strahlenther Onkol. 2012 Nov;188(11):982-9. doi: 10.1007/s00066-012-0169-1. Epub 2012 Oct 11. Strahlenther Onkol. 2012. PMID: 23053142
Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.
Matuschek C, Bölke E, Belka C, Ganswindt U, Henke M, Stegmaier P, Bamberg M, Welz S, Debus J, Gioules A, Voigt A, Volk G, Ohmann C, Wiegel T, Budach V, Stuschke M, Schipper J, Gerber PA, Budach W. Matuschek C, et al. Among authors: ganswindt u. Strahlenther Onkol. 2013 Aug;189(8):625-31. doi: 10.1007/s00066-013-0378-2. Epub 2013 Jul 5. Strahlenther Onkol. 2013. PMID: 23824104 Clinical Trial.
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M. Schanne DH, et al. Among authors: ganswindt u. Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27. Strahlenther Onkol. 2015. PMID: 25159135
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.
Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Wieland W, Eder F, Hofstädter F, Schilling D, Sievert KD, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid KW, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Gratzke C, Stief C, Wiegel T, Haese A. Karl A, et al. Among authors: ganswindt u. Radiother Oncol. 2015 Jul;116(1):119-24. doi: 10.1016/j.radonc.2015.06.021. Epub 2015 Jun 29. Radiother Oncol. 2015. PMID: 26138059
183 results